Keyphrases
Chronic Pancreatitis
100%
EphA2
79%
Older Adults
72%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
66%
Colipase
51%
Acute Recurrent Pancreatitis
46%
Adipose Triglyceride Lipase
44%
Acute Pancreatitis
43%
Lipase
43%
Pancreatitis
42%
Pancreatic Lipase
41%
INSPPIRE
39%
Spoken Word Recognition
38%
Acute Myeloid Leukemia
38%
Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
38%
New Molecular Entity
38%
FDA-approved Drugs
36%
Pediatric Pancreatitis
33%
Pediatric
31%
Speech Perception
31%
Diffuse Large B-cell Lymphoma (DLBCL)
29%
Relapsed or Refractory
28%
Spoken Word
26%
Confidence Interval
25%
Speaking Rate
25%
Tyrosine Kinase
24%
Carboxylesterase 1 (CES1)
24%
Overall Survival
23%
Stimulus Variability
23%
Myelodysplastic Syndrome
22%
Porcine Pancreatic Lipase
21%
Overexpression
21%
Phase II Study
19%
Granulocyte Colony-stimulating Factor (G-CSF)
19%
Pancreas
18%
Risk Factors
18%
Plerixafor
18%
Mantle Cell Lymphoma
17%
Diabetes
17%
Lymphoma Patients
17%
False Memory
17%
Tumor Cells
15%
Chemotherapy
15%
Age Differences
15%
Progression-free Survival
15%
Aging Effect
15%
New Medicines
15%
Rituximab
15%
Fat Digestion
14%
Normal Hearing
14%
U.S. Food
14%
Cell Adhesion
14%
Infectious Diseases
14%
Decitabine
14%
Autologous Transplantation
14%
Lenalidomide
13%
Subglottal Resonances
13%
Audiovisual Speech Perception
13%
Triglycerides
13%
Word Identification
13%
Follicular Lymphoma
13%
Relapsed Lymphoma
13%
Complementary DNA (cDNA)
13%
Complete Remission
13%
Hearing Impairment
12%
EphA2 Receptor
12%
Tumor
12%
Lexical Competition
12%
Hodgkin Lymphoma
12%
Cytarabine
12%
Older Patients
12%
Dietary Fat
12%
Integrin
11%
Etiology
11%
E-cadherin
11%
Ovarian Cancer
11%
Frequency Discrimination
11%
Hazard Ratio
10%
Bile Salts
10%
Stem Cells
10%
Word Recognition
10%
Tyrosine Phosphorylation
10%
Gene Perturbation
10%
Inhibitory Control
10%
Mental Lexicon
10%
Lipase Activity
9%
Overall Response Rate
9%
Lipase Gene
9%
L2 Vocabulary Learning
9%
Drug Development
9%
Malignant Cells
9%
Epithelial Cells
9%
Azacitidine
9%
Approved Drugs
9%
Working Memory
9%
Pancreatic Cancer
9%
Stem Cell Mobilization
9%
Vowels
9%
Pharmaceutical Companies
8%
Fundamental Frequency
8%
Medicine and Dentistry
Chronic Pancreatitis
84%
Pediatrics
60%
Pancreatitis
58%
Acute Pancreatitis
40%
Hematopoietic Cell
36%
Diseases
32%
Cell Transplantation
30%
Triacylglycerol Lipase
29%
Overall Survival
28%
Acute Myeloid Leukemia
27%
Neoplasm
22%
Diffuse Large B-Cell Lymphoma
22%
Diabetes
18%
Plerixafor
17%
Medicine
17%
Protein Tyrosine Kinase
16%
Mantle Cell Lymphoma
15%
Oncology
14%
Hodgkin's Lymphoma
13%
Ovarian Cancer
13%
Infection
12%
Progression Free Survival
12%
Myelodysplastic Syndrome
11%
Autotransplantation
11%
Granulocyte Colony Stimulating Factor
10%
Rituximab
10%
Clinical Trial
10%
Malignant Neoplasm
10%
Cytotoxic T-Cell
9%
Autologous Stem Cell Transplantation
9%
Infectious Disease
9%
Decitabine
9%
Hematopoietic Stem Cell Transplantation
9%
Classical Hodgkin Lymphoma
9%
Lenalidomide
9%
Stem Cell
9%
Pancreas Cancer
9%
Tumor Cell
8%
Hazard Ratio
8%
Pancreas Disease
7%
Cytotoxicity
7%
Orphan
7%
Ephrin Receptor A2
7%
Pancreas Enzyme
7%
Biological Product
7%
Tumor Progression
7%
Azacitidine
7%
Cell Therapy
6%
Chemokine Receptor CXCR4 Antagonist
6%
Prostatic Intraepithelial Neoplasia
6%
Follicular Lymphoma
6%
Stem Cell Mobilization
6%
Fat Intake
6%
Conditioning
6%
Disease Burden
6%
Pathogen
6%
T Cell
6%
Prostate Cancer
6%
Genetic Risk Factor
6%
Cytarabine
5%
Cancer
5%
Reduced Intensity Conditioning
5%
Angiogenesis
5%
Prostate Adenocarcinoma
5%
Allogeneic Stem Cell Transplantation
5%
Monoclonal Antibody
5%
Leukemia
5%
Myeloablative Conditioning
5%
Exocrine Pancreatic Insufficiency
5%
Polyethylene Terephthalate
5%
Triacylglycerol
5%
Gene Mutation
5%
Breast Cancer
5%
Kidney Disorder
5%
Allograft
5%
Cardiovascular Disease
5%
Hypomethylating Agent
5%
Epithelial Cell
5%
Virus
5%
Lymphoma Cell
5%
Krukenberg Tumor
5%
Disease
5%